mintneuro.com
AI NativeEnabling next-generation neural implants with advanced semiconductor technology.
Published Oct 9, 2026
| Starting price | Not publicly disclosed | RHS2116: $292 bare die or $392 QFN, quantities 1–24 | Project quote; no public standard tariff found | Project quote; no public standard tariff found |
| Potential fit | Partner-led neural-device programmes seeking modular, implant-focused ICs | Research electrophysiology and documented recording/stimulation IC integration | Bespoke medical ASICs and miniaturised implant modules | Buyers seeking broader implant-system integration |
| Key strength | Purpose-built modular platform and named development relationships | Public pricing, datasheets, software and development resources | In-house ASIC design, qualification and implant-module expertise | Electronics, electrodes, leads and hermetic encapsulation |
| Key weakness | Sparse public benchmarks and production qualification evidence | Research systems are not a complete implant platform | Custom scope entails project-specific engineering and qualification | Broader scope may be unnecessary for chip-only buyers |
| Published specification advantage | Full comparative matrix not located | RHS2116: 16 channels, up to 40 kSamples/s/channel, typical 2.4 µV RMS noise | Custom specifications | Platform/system-specific specifications |
—
MintNeuro’s October 7, 2026 financing and named partner milestones indicate movement toward commercial scale-up. Tech.eu corroborates the funding announcement but does not independently validate comparative chip performance. No defensible market-share percentage, shipment share or installed-base estimate was found. (tech.eu)
Analyst conclusion: MintNeuro’s potential advantage is implant-focused reuse and system co-design—not the mere existence of neural sensing or stimulation ICs. Superiority on power, area, safety or total development cost remains unproven publicly.